Search Results

5 results

  1. TSRC, Tob. Sci. Res. Conf., 2011, 65, abstr. 62

    Field evaluation of an interspecific hybrid as a containment strategy for plant-made pharmaceutical applications in tobacco.

    CHAMBERS O.(1); RICE J.H.(2); MUNDELL R.(1); MILLWOOD R.J.(2); STEWART C.N.(2); DAVIES H.M.(1)
    (1) Kentucky Tobacco Research & Development Center, Lexington, KY, USA; (2) University of Tennessee, Knoxville, TN, USA
    Biotechnology allows plants to be utilized for the production of non-native pharmaceutical and industrial materials with tobacco being the most commonly exploited plant for these applications. Genetic containment is a concern for these plant...
  2. TSRC, Tob. Sci. Res. Conf., 2011, 65, abstr. 63

    Effect of bale weight on TSNA content of cured burley tobacco in large bales.

    DENTON P.(1,2); VELANDIA M.(1); WITCHER V.(1)
    (1) University of Tennessee, Knoxville, TN USA; (2) University of Kentucky, Lexington, KY USA
    Cured burley tobacco was placed in large bales (106 cm x 106 cm x 103 cm) at varying weights to investigate the effect of density on TSNA formation during storage. Bale weights were 246, 309 and 340 kg in 2006-7, and 250 and 362 kg in 2008. Tobacco...
  3. CORESTA Congress, Edinburgh, 2010, AP 18; TSRC, Tob. Sci. Res. Conf., 2010, 64, abstr. 43

    Potential applications of 'GM' technology in the production of tobacco for its traditional uses

    FORTNUM B.A.; PETERSON P.D.; DAVIES M.; CHAMBERS O.; THOMAS P.
    Clemson University, Dept. of Entomology Soils and Plant Sciences, Pee Dee REC, Florence, SC, USA
    The flue-cured and Burley tobacco industries have thus far relied solely on the intrinsic gene-pool of the tobacco plant itself for traits that enhance yield, disease resistance, leaf quality etc. Meanwhile, over the last 25 years the tobacco plant...